Medigene AG Performance
| MDGEFDelisted Stock | USD 2.59 0.00 0.00% |
The company secures a Beta (Market Risk) of -1.59, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Medigene are expected to decrease by larger amounts. On the other hand, during market turmoil, Medigene is expected to outperform it. Medigene AG right now secures a risk of 0.0%. Please verify Medigene AG variance, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Medigene AG will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medigene AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Medigene is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 30 M | |
| Total Cashflows From Investing Activities | 4 M |
Medigene |
Medigene Relative Risk vs. Return Landscape
If you would invest 259.00 in Medigene AG on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Medigene AG or generate 0.0% return on investment over 90 days. Medigene AG is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Medigene, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medigene Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medigene's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Medigene AG, and traders can use it to determine the average amount a Medigene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MDGEF |
Based on monthly moving average Medigene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medigene by adding Medigene to a well-diversified portfolio.
Medigene Fundamentals Growth
Medigene Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Medigene, and Medigene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medigene Pink Sheet performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0887 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 30.5 M | |||
| Shares Outstanding | 24.56 M | |||
| Price To Earning | 5.26 X | |||
| Price To Book | 0.92 X | |||
| Price To Sales | 1.86 X | |||
| Revenue | 10.46 M | |||
| EBITDA | (6.49 M) | |||
| Cash And Equivalents | 39.38 M | |||
| Cash Per Share | 1.60 X | |||
| Total Debt | 3.73 M | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 2.41 X | |||
| Cash Flow From Operations | (10.75 M) | |||
| Earnings Per Share | 0.42 X | |||
| Total Asset | 59.47 M | |||
About Medigene Performance
By analyzing Medigene's fundamental ratios, stakeholders can gain valuable insights into Medigene's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medigene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medigene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company was founded in 1994 and is headquartered in Munich, Germany. Medigene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 61 people.Things to note about Medigene AG performance evaluation
Checking the ongoing alerts about Medigene for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Medigene AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medigene AG is not yet fully synchronised with the market data | |
| Medigene AG has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 10.46 M. Net Loss for the year was (9.98 M) with profit before overhead, payroll, taxes, and interest of 9.1 M. | |
| Medigene AG has accumulated about 39.38 M in cash with (10.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.6. |
- Analyzing Medigene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medigene's stock is overvalued or undervalued compared to its peers.
- Examining Medigene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medigene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medigene's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medigene's pink sheet. These opinions can provide insight into Medigene's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Medigene Pink Sheet
If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |